Lana Rhoades 
Pevita Pearce 
Amara Maple 
Yuyun Lusiyani 
Laila Zulfa The Lifelong Battle: A Mother’s Journey Through Eating Disorder Treatment
The insidious nature of eating disorders often belies their profound and lasting impact, a reality underscored by the personal narrative…
Fransisca Siska The Endocrine Society Launches Rare Endocrine Disease Fellows Program to Address Critical Gaps in Specialized Medical Training and Patient Care
The Endocrine Society has officially announced the commencement of its Rare Endocrine Disease (RED) Fellows Program, a comprehensive educational initiative…
Senate Vote Sets up a Clash Over Boundary Waters Environmental Safeguards
The United States Senate is advancing a high-stakes resolution aimed at rescinding a 20-year moratorium on mineral leasing within the…
Julia Chirkova Navigating the Labyrinth: Empowering High School Students with Positive Body Image and Self-Esteem
The formative years of high school represent a critical juncture for adolescents, a period characterized by intense self-discovery and the…
Shifts in Federal Environmental Oversight and the Redefinition of Agency Priorities in the 2025 Administrative Transition
The transition of power within federal agencies often precipitates shifts in policy, but the 2025 change in leadership at the…
Separating Mental and Physical Recovery: A Crucial Distinction in Eating Disorder Treatment
The journey through eating disorder recovery is often a complex, multifaceted process that extends far beyond the restoration of physical…
Cardiovascular Health Supplement Market Poised for Growth, Experts Highlight Innovation and Emerging Ingredients
The pursuit of optimal cardiovascular health within the dietary supplement industry is far more intricate than achieving a sub-4:00 mile.…
Assault Fitness AssaultBike Pro X Review (2025): Assault’s Best Bike Yet?
The Assault Bike ProX has emerged as a significant contender in the high-intensity cardio equipment market, offering a full-body, low-impact…
Eva Lovia Eli Lilly Announces Pivotal Phase 3 Success for Orforglipron as Oral GLP-1 Agonist Demonstrates Superiority in Global Diabetes Trials
In a landmark development for the treatment of type 2 diabetes and metabolic health, Eli Lilly and Company has announced…
Women in Agriculture at Elevated Risk of More Aggressive Breast Cancer from Pesticides Study Finds
A landmark study published in the peer-reviewed journal PLOS ONE has uncovered a harrowing link between chronic pesticide exposure and…
